BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35648209)

  • 1. Contrast-enhanced mammography for the assessment of screening recalls: a two-centre study.
    Cozzi A; Schiaffino S; Fanizza M; Magni V; Menicagli L; Monaco CG; Benedek A; Spinelli D; Di Leo G; Di Giulio G; Sardanelli F
    Eur Radiol; 2022 Nov; 32(11):7388-7399. PubMed ID: 35648209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of stereotactic core needle biopsy in women recalled for suspicious calcifications at screening mammography: frequency, causes, and final outcome in a multi-institutional, observational follow-up study.
    Duijm LEM; Strobbe LJA; van Breest Smallenburg V; Vreuls W; Boerman T; van Beek HC; Op de Coul-Froger CL; Setz-Pels W; Voogd AC
    Eur Radiol; 2022 Nov; 32(11):7420-7429. PubMed ID: 35486173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of MRI contrast enhancement in biopsy decision of suspicious mammographic microcalcifications: a prospective multicenter study.
    Taskin F; Kalayci CB; Tuncbilek N; Soydemir E; Kurt N; Kaya H; Aribal E
    Eur Radiol; 2021 Mar; 31(3):1718-1726. PubMed ID: 32939619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
    Bitencourt AG; Lima EN; Macedo BR; Conrado JL; Marques EF; Chojniak R
    Eur Radiol; 2017 May; 27(5):1893-1900. PubMed ID: 27585658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
    Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
    Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of MRI-Directed Contrast-Enhanced Mammography for Biopsy Planning for Suspicious MRI-Detected Breast Lesions.
    Nida BA; Rooney TB; Miller MM
    AJR Am J Roentgenol; 2023 Feb; 220(2):202-211. PubMed ID: 36000664
    [No Abstract]   [Full Text] [Related]  

  • 7. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
    Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
    Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of contrast-enhanced mammography in the preoperative detection of ductal carcinoma in situ of the breasts: a comparison with low-energy image and magnetic resonance imaging.
    Wang L; Wang P; Shao H; Li J; Yang Q
    Eur Radiol; 2024 May; 34(5):3342-3351. PubMed ID: 37853174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI.
    Wengert GJ; Pipan F; Almohanna J; Bickel H; Polanec S; Kapetas P; Clauser P; Pinker K; Helbich TH; Baltzer PAT
    Eur Radiol; 2020 Mar; 30(3):1451-1459. PubMed ID: 31797077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis.
    Ploumen RAW; de Mooij CM; Gommers S; Keymeulen KBMI; Smidt ML; van Nijnatten TJA
    Eur Radiol; 2023 Aug; 33(8):5423-5435. PubMed ID: 37020070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast enhanced mammography in breast cancer surveillance.
    Elder K; Matheson J; Nickson C; Box G; Ellis J; Mou A; Shadbolt C; Park A; Tay J; Rose A; Mann GB
    Breast Cancer Res Treat; 2023 Jun; 199(2):221-230. PubMed ID: 36966271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Performance of Contrast-enhanced Mammography, Abbreviated Breast MRI, and Standard Breast MRI for Breast Cancer Screening.
    Lawson MB; Partridge SC; Hippe DS; Rahbar H; Lam DL; Lee CI; Lowry KP; Scheel JR; Parsian S; Li I; Biswas D; Bryant ML; Lee JM
    Radiology; 2023 Aug; 308(2):e230576. PubMed ID: 37581498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspicious breast calcifications undergoing stereotactic biopsy in women ages 70 and over: Breast cancer incidence by BI-RADS descriptors.
    Grimm LJ; Johnson DY; Johnson KS; Baker JA; Soo MS; Hwang ES; Ghate SV
    Eur Radiol; 2017 Jun; 27(6):2275-2281. PubMed ID: 27752832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recall and Outcome of Screen-detected Microcalcifications during 2 Decades of Mammography Screening in the Netherlands National Breast Screening Program.
    Luiten JD; Voogd AC; Luiten EJT; Broeders MJM; Roes KCB; Tjan-Heijnen VCG; Duijm LEM
    Radiology; 2020 Mar; 294(3):528-537. PubMed ID: 31990268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.
    Clauser P; Baltzer PAT; Kapetas P; Hoernig M; Weber M; Leone F; Bernathova M; Helbich TH
    J Magn Reson Imaging; 2020 Aug; 52(2):589-595. PubMed ID: 32061002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplifying Breast Imaging Reporting and Data System classification of mammograms with pure suspicious calcifications.
    Menezes GL; Winter-Warnars GA; Koekenbier EL; Groen EJ; Verkooijen HM; Pijnappel RM
    J Med Screen; 2018 Jun; 25(2):82-87. PubMed ID: 28691862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced mammography-guided biopsy: technical feasibility and first outcomes.
    Alcantara R; Posso M; Pitarch M; Arenas N; Ejarque B; Iotti V; Besutti G
    Eur Radiol; 2023 Jan; 33(1):417-428. PubMed ID: 35895121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of ductal carcinoma in-situ from benign micro-calcifications by dedicated breast computed tomography.
    Aminololama-Shakeri S; Abbey CK; Gazi P; Prionas ND; Nosratieh A; Li CS; Boone JM; Lindfors KK
    Eur J Radiol; 2016 Jan; 85(1):297-303. PubMed ID: 26520874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.